Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis

By sjmartinez • September 8, 2023

Murthy V, Gafita A, Thin P, Nguyen K, Grogan T, Shen J, Drakaki A, Rettig M, Czernin J, Calais J. Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with ¹⁷⁷Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis. J Nucl Med. 2023 Sep 7:jnumed.122.265155. doi: 10.2967/jnumed.122.265155. Epub ahead of print. PMID: 37678927.

Tags: 177Lu-PSMA, Cardiology/Epi, end-of-treatment PET, Hematology/Oncology, metastatic castration-resistant prostate cancer, PSMA-PET, Publications, radioligand therapy

The noncanonical NFκB pathway: Regulatory mechanisms in health and disease

Rodriguez BN, Huang H, Chia JJ, Hoffmann A. The noncanonical NFκB pathway: Regulatory mechanisms in health and disease. WIREs Mech Dis. 2024 Nov-Dec;16(6):e1646. doi: 10.1002/wsbm.1646.[...]

Acute Coronary Syndrome in Women

Cader FA, Sareen N, Press MC. Acute Coronary Syndrome in Women. Interv Cardiol Clin. 2025 Jan;14(1):9-19. doi: 10.1016/j.iccl.2024.08.011. PMID: 39537292.

The Rebirth of Intraoperative Electrophysiological Mapping for Complex Congenital Heart Disease

Moore JP, Shivkumar K. The Rebirth of Intraoperative Electrophysiological Mapping for Complex Congenital Heart Disease. J Am Coll Cardiol. 2024 Nov 19;84(21):2113-2115. doi: 10.1016/j.jacc.2024.08.078. PMID:[...]